Exact Mass: 481.413087

Exact Mass Matches: 481.413087

Found 134 metabolites which its exact mass value is equals to given mass value 481.413087, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cer(d18:1/12:0)

N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-octadecanamide

C30H59NO3 (481.4494704)


Ceramides (N-acylsphingosine) are one of the hydrolysis byproducts of sphingomyelin by the enzyme sphingomyelinase (sphingomyelin phosphorylcholine phosphohydrolase E.C.3.1.4.12) which has been identified in the subcellular fractions of human epidermis (PMID 25935) and many other tissues. They can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID 14998372). Is key in the biosynthesis of glycosphingolipids and gangliosides. Ceramide is found in rice. Ceramides (N-acylsphingosine) are one of the hydrolysis byproducts of sphingomyelin by the enzyme sphingomyelinase (sphingomyelin phosphorylcholine phosphohydrolase E.C.3.1.4.12) which has been identified in the subcellular fractions of human epidermis (PMID 25935) and many other tissues. They can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID 14998372). Is key in the biosynthesis of glycosphingolipids and gangliosides.

   

(13Z)-Docos-13-enoylcarnitine

3-(docos-13-enoyloxy)-4-(trimethylazaniumyl)butanoate

C29H55NO4 (481.413087)


(13Z)-docos-13-enoylcarnitine is an acylcarnitine. More specifically, it is an (13Z)-docos-13-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (13Z)-docos-13-enoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (13Z)-docos-13-enoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(11Z)-Docos-11-enoylcarnitine

3-(docos-11-enoyloxy)-4-(trimethylazaniumyl)butanoate

C29H55NO4 (481.413087)


(11Z)-docos-11-enoylcarnitine is an acylcarnitine. More specifically, it is an (11Z)-docos-11-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (11Z)-docos-11-enoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (11Z)-docos-11-enoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

N-Nervonoyl Aspartic acid

2-(tetracos-15-enamido)butanedioic acid

C28H51NO5 (481.37670360000004)


N-nervonoyl aspartic acid, also known as N-nervonoyl aspartate belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Nervonic acid amide of Aspartic acid. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Nervonoyl Aspartic acid is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Nervonoyl Aspartic acid is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   
   

Cer[NS] d30:1

Cer[NS] d30:1

C30H59NO3 (481.4494704)


Found in mouse small intestine; TwoDicalId=16; MgfFile=160907_Small_Intestine_EPA_Neg_10; MgfId=810

   

Lactosyl(ß) C12 Ceramide

Lactosyl(ß) C12 Ceramide

C30H59NO3 (481.4494704)


   

Cer(d14:1/16:0)

N-(hexadecanoyl)-tetradecasphing-4-enine

C30H59NO3 (481.4494704)


   

Ceramide (d18:1/12:0)

Ceramide (d18:1/12:0)

C30H59NO3 (481.4494704)


   

Cer[NS]

N-(hexadecanoyl)-tetradecasphing-4-enine

C30H59NO3 (481.4494704)


   

Brassidylcarnitine, (+/-)-

Brassidylcarnitine, (+/-)-

C29H55NO4 (481.413087)


   

N-[(E)-1,3-dihydroxyoctadec-4-en-2-yl]dodecanamide

N-[(E)-1,3-dihydroxyoctadec-4-en-2-yl]dodecanamide

C30H59NO3 (481.4494704)


   

N-(2-hydroxyundecanoyl)-sphinga-4,8-dienine

N-(2-hydroxyundecanoyl)-sphinga-4,8-dienine

C29H55NO4 (481.413087)


   
   

(11Z)-Docos-11-enoylcarnitine

(11Z)-Docos-11-enoylcarnitine

C29H55NO4 (481.413087)


   

N-dodecanoyl-3-oxosphinganine

N-dodecanoyl-3-oxosphinganine

C30H59NO3 (481.4494704)


   

L-erythro-N-dodecanoylsphingosine

L-erythro-N-dodecanoylsphingosine

C30H59NO3 (481.4494704)


   
   
   
   
   
   
   
   
   

N-[(E)-1,3-dihydroxyhexacos-4-en-2-yl]butanamide

N-[(E)-1,3-dihydroxyhexacos-4-en-2-yl]butanamide

C30H59NO3 (481.4494704)


   

N-[(E)-1,3-dihydroxyoct-4-en-2-yl]docosanamide

N-[(E)-1,3-dihydroxyoct-4-en-2-yl]docosanamide

C30H59NO3 (481.4494704)


   

N-[(E)-1,3-dihydroxytricos-4-en-2-yl]heptanamide

N-[(E)-1,3-dihydroxytricos-4-en-2-yl]heptanamide

C30H59NO3 (481.4494704)


   

N-[(E)-1,3-dihydroxynon-4-en-2-yl]henicosanamide

N-[(E)-1,3-dihydroxynon-4-en-2-yl]henicosanamide

C30H59NO3 (481.4494704)


   

(Z)-N-(1,3-dihydroxyoctan-2-yl)docos-13-enamide

(Z)-N-(1,3-dihydroxyoctan-2-yl)docos-13-enamide

C30H59NO3 (481.4494704)


   

N-[(E)-1,3-dihydroxyheptacos-4-en-2-yl]propanamide

N-[(E)-1,3-dihydroxyheptacos-4-en-2-yl]propanamide

C30H59NO3 (481.4494704)


   

N-[(E)-1,3-dihydroxydocos-4-en-2-yl]octanamide

N-[(E)-1,3-dihydroxydocos-4-en-2-yl]octanamide

C30H59NO3 (481.4494704)


   

N-[(E)-1,3-dihydroxypentacos-4-en-2-yl]pentanamide

N-[(E)-1,3-dihydroxypentacos-4-en-2-yl]pentanamide

C30H59NO3 (481.4494704)


   

N-[(E)-1,3-dihydroxyoctacos-4-en-2-yl]acetamide

N-[(E)-1,3-dihydroxyoctacos-4-en-2-yl]acetamide

C30H59NO3 (481.4494704)


   

N-[(E)-1,3-dihydroxytetracos-4-en-2-yl]hexanamide

N-[(E)-1,3-dihydroxytetracos-4-en-2-yl]hexanamide

C30H59NO3 (481.4494704)


   

N-[(E)-1,3-dihydroxyhenicos-4-en-2-yl]nonanamide

N-[(E)-1,3-dihydroxyhenicos-4-en-2-yl]nonanamide

C30H59NO3 (481.4494704)


   

(Z)-N-(1,3-dihydroxynonan-2-yl)henicos-11-enamide

(Z)-N-(1,3-dihydroxynonan-2-yl)henicos-11-enamide

C30H59NO3 (481.4494704)


   

(Z)-N-(1,3-dihydroxydecan-2-yl)icos-11-enamide

(Z)-N-(1,3-dihydroxydecan-2-yl)icos-11-enamide

C30H59NO3 (481.4494704)


   

N-[(E)-1,3-dihydroxyicos-4-en-2-yl]decanamide

N-[(E)-1,3-dihydroxyicos-4-en-2-yl]decanamide

C30H59NO3 (481.4494704)


   

N-[(E)-1,3-dihydroxytridec-4-en-2-yl]heptadecanamide

N-[(E)-1,3-dihydroxytridec-4-en-2-yl]heptadecanamide

C30H59NO3 (481.4494704)


   

(Z)-N-(1,3-dihydroxytetradecan-2-yl)hexadec-9-enamide

(Z)-N-(1,3-dihydroxytetradecan-2-yl)hexadec-9-enamide

C30H59NO3 (481.4494704)


   

N-[(E)-1,3-dihydroxyundec-4-en-2-yl]nonadecanamide

N-[(E)-1,3-dihydroxyundec-4-en-2-yl]nonadecanamide

C30H59NO3 (481.4494704)


   

N-[(E)-1,3-dihydroxydodec-4-en-2-yl]octadecanamide

N-[(E)-1,3-dihydroxydodec-4-en-2-yl]octadecanamide

C30H59NO3 (481.4494704)


   

(Z)-N-(1,3-dihydroxyundecan-2-yl)nonadec-9-enamide

(Z)-N-(1,3-dihydroxyundecan-2-yl)nonadec-9-enamide

C30H59NO3 (481.4494704)


   

(Z)-N-(1,3-dihydroxyheptadecan-2-yl)tridec-9-enamide

(Z)-N-(1,3-dihydroxyheptadecan-2-yl)tridec-9-enamide

C30H59NO3 (481.4494704)


   

N-[(E)-1,3-dihydroxynonadec-4-en-2-yl]undecanamide

N-[(E)-1,3-dihydroxynonadec-4-en-2-yl]undecanamide

C30H59NO3 (481.4494704)


   

(Z)-N-(1,3-dihydroxytridecan-2-yl)heptadec-9-enamide

(Z)-N-(1,3-dihydroxytridecan-2-yl)heptadec-9-enamide

C30H59NO3 (481.4494704)


   

(Z)-N-(1,3-dihydroxydodecan-2-yl)octadec-9-enamide

(Z)-N-(1,3-dihydroxydodecan-2-yl)octadec-9-enamide

C30H59NO3 (481.4494704)


   

N-[(E)-1,3-dihydroxydec-4-en-2-yl]icosanamide

N-[(E)-1,3-dihydroxydec-4-en-2-yl]icosanamide

C30H59NO3 (481.4494704)


   
   

N-[(8E,12E)-1,3,4-trihydroxyhexadeca-8,12-dien-2-yl]tridecanamide

N-[(8E,12E)-1,3,4-trihydroxyhexadeca-8,12-dien-2-yl]tridecanamide

C29H55NO4 (481.413087)


   

N-[(E)-1,3-dihydroxyheptadec-4-en-2-yl]tridecanamide

N-[(E)-1,3-dihydroxyheptadec-4-en-2-yl]tridecanamide

C30H59NO3 (481.4494704)


   

(Z)-N-(1,3-dihydroxypentadecan-2-yl)pentadec-9-enamide

(Z)-N-(1,3-dihydroxypentadecan-2-yl)pentadec-9-enamide

C30H59NO3 (481.4494704)


   

N-[(E)-1,3-dihydroxytetradec-4-en-2-yl]hexadecanamide

N-[(E)-1,3-dihydroxytetradec-4-en-2-yl]hexadecanamide

C30H59NO3 (481.4494704)


   

N-[(8E,12E)-1,3,4-trihydroxypentadeca-8,12-dien-2-yl]tetradecanamide

N-[(8E,12E)-1,3,4-trihydroxypentadeca-8,12-dien-2-yl]tetradecanamide

C29H55NO4 (481.413087)


   

(Z)-N-[(E)-1,3,4-trihydroxyhexadec-8-en-2-yl]tridec-8-enamide

(Z)-N-[(E)-1,3,4-trihydroxyhexadec-8-en-2-yl]tridec-8-enamide

C29H55NO4 (481.413087)


   

N-[(8E,12E)-1,3,4-trihydroxyheptadeca-8,12-dien-2-yl]dodecanamide

N-[(8E,12E)-1,3,4-trihydroxyheptadeca-8,12-dien-2-yl]dodecanamide

C29H55NO4 (481.413087)


   

(Z)-N-[(E)-1,3,4-trihydroxyheptadec-8-en-2-yl]dodec-5-enamide

(Z)-N-[(E)-1,3,4-trihydroxyheptadec-8-en-2-yl]dodec-5-enamide

C29H55NO4 (481.413087)


   

N-[(E)-1,3-dihydroxyhexadec-4-en-2-yl]tetradecanamide

N-[(E)-1,3-dihydroxyhexadec-4-en-2-yl]tetradecanamide

C30H59NO3 (481.4494704)


   

(Z)-N-[(E)-1,3,4-trihydroxytetradec-8-en-2-yl]pentadec-9-enamide

(Z)-N-[(E)-1,3,4-trihydroxytetradec-8-en-2-yl]pentadec-9-enamide

C29H55NO4 (481.413087)


   

(Z)-N-[(E)-1,3,4-trihydroxypentadec-8-en-2-yl]tetradec-9-enamide

(Z)-N-[(E)-1,3,4-trihydroxypentadec-8-en-2-yl]tetradec-9-enamide

C29H55NO4 (481.413087)


   

(Z)-N-(1,3-dihydroxyhexadecan-2-yl)tetradec-9-enamide

(Z)-N-(1,3-dihydroxyhexadecan-2-yl)tetradec-9-enamide

C30H59NO3 (481.4494704)


   

N-[(E)-1,3-dihydroxypentadec-4-en-2-yl]pentadecanamide

N-[(E)-1,3-dihydroxypentadec-4-en-2-yl]pentadecanamide

C30H59NO3 (481.4494704)


   

N-[(8E,12E)-1,3,4-trihydroxytetradeca-8,12-dien-2-yl]pentadecanamide

N-[(8E,12E)-1,3,4-trihydroxytetradeca-8,12-dien-2-yl]pentadecanamide

C29H55NO4 (481.413087)


   

Cer 14:1;2O/15:1;(2OH)

Cer 14:1;2O/15:1;(2OH)

C29H55NO4 (481.413087)


   

Cer 16:1;2O/13:1;(2OH)

Cer 16:1;2O/13:1;(2OH)

C29H55NO4 (481.413087)


   

Cer 15:2;2O/14:0;(3OH)

Cer 15:2;2O/14:0;(3OH)

C29H55NO4 (481.413087)


   

Cer 15:2;2O/14:0;(2OH)

Cer 15:2;2O/14:0;(2OH)

C29H55NO4 (481.413087)


   
   

Cer 15:1;2O/14:1;(3OH)

Cer 15:1;2O/14:1;(3OH)

C29H55NO4 (481.413087)


   

Cer 17:1;2O/12:1;(2OH)

Cer 17:1;2O/12:1;(2OH)

C29H55NO4 (481.413087)


   
   

Cer 14:2;2O/15:0;(3OH)

Cer 14:2;2O/15:0;(3OH)

C29H55NO4 (481.413087)


   
   

Cer 15:1;2O/14:1;(2OH)

Cer 15:1;2O/14:1;(2OH)

C29H55NO4 (481.413087)


   

Cer 17:2;2O/12:0;(2OH)

Cer 17:2;2O/12:0;(2OH)

C29H55NO4 (481.413087)


   

Cer 14:1;2O/15:1;(3OH)

Cer 14:1;2O/15:1;(3OH)

C29H55NO4 (481.413087)


   

Cer 17:1;2O/12:1;(3OH)

Cer 17:1;2O/12:1;(3OH)

C29H55NO4 (481.413087)


   

Cer 16:2;2O/13:0;(2OH)

Cer 16:2;2O/13:0;(2OH)

C29H55NO4 (481.413087)


   

Cer 14:2;2O/15:0;(2OH)

Cer 14:2;2O/15:0;(2OH)

C29H55NO4 (481.413087)


   

Cer 17:2;2O/12:0;(3OH)

Cer 17:2;2O/12:0;(3OH)

C29H55NO4 (481.413087)


   

Cer 16:2;2O/13:0;(3OH)

Cer 16:2;2O/13:0;(3OH)

C29H55NO4 (481.413087)


   

Cer 16:1;2O/13:1;(3OH)

Cer 16:1;2O/13:1;(3OH)

C29H55NO4 (481.413087)


   

(Z)-N-(1,3-dihydroxyheptadecan-2-yl)tridec-8-enamide

(Z)-N-(1,3-dihydroxyheptadecan-2-yl)tridec-8-enamide

C30H59NO3 (481.4494704)


   

(Z)-N-(1,3-dihydroxytetradecan-2-yl)hexadec-7-enamide

(Z)-N-(1,3-dihydroxytetradecan-2-yl)hexadec-7-enamide

C30H59NO3 (481.4494704)


   

(Z)-N-(1,3-dihydroxyoctadecan-2-yl)dodec-5-enamide

(Z)-N-(1,3-dihydroxyoctadecan-2-yl)dodec-5-enamide

C30H59NO3 (481.4494704)


   

N-(decanoyl)-4E-eicosasphingenine

N-(decanoyl)-4E-eicosasphingenine

C30H59NO3 (481.4494704)


   

N-(tridecanoyl)-4E-heptadecasphingenine

N-(tridecanoyl)-4E-heptadecasphingenine

C30H59NO3 (481.4494704)


   

N-(tetradecanoyl)-4E-hexadecasphingenine

N-(tetradecanoyl)-4E-hexadecasphingenine

C30H59NO3 (481.4494704)


   

N-(pentadecanoyl)-4E-pentadecasphingenine

N-(pentadecanoyl)-4E-pentadecasphingenine

C30H59NO3 (481.4494704)


   

N-[(E,2S,3R)-1,3-dihydroxypentadec-8-en-2-yl]pentadecanamide

N-[(E,2S,3R)-1,3-dihydroxypentadec-8-en-2-yl]pentadecanamide

C30H59NO3 (481.4494704)


   

N-[(E,2S,3R)-1,3-dihydroxytetradec-8-en-2-yl]hexadecanamide

N-[(E,2S,3R)-1,3-dihydroxytetradec-8-en-2-yl]hexadecanamide

C30H59NO3 (481.4494704)


   

(E)-N-[(2S,3R)-1,3-dihydroxytetradecan-2-yl]hexadec-9-enamide

(E)-N-[(2S,3R)-1,3-dihydroxytetradecan-2-yl]hexadec-9-enamide

C30H59NO3 (481.4494704)


   

N-[(E,2S,3R)-1,3-dihydroxyhexadec-8-en-2-yl]tetradecanamide

N-[(E,2S,3R)-1,3-dihydroxyhexadec-8-en-2-yl]tetradecanamide

C30H59NO3 (481.4494704)


   

N-[(E,2S,3R)-1,3-dihydroxyoctadec-8-en-2-yl]dodecanamide

N-[(E,2S,3R)-1,3-dihydroxyoctadec-8-en-2-yl]dodecanamide

C30H59NO3 (481.4494704)


   

N-[(E,2S,3R)-1,3-dihydroxyheptadec-8-en-2-yl]tridecanamide

N-[(E,2S,3R)-1,3-dihydroxyheptadec-8-en-2-yl]tridecanamide

C30H59NO3 (481.4494704)


   

N-[(E,2S,3R)-1,3-dihydroxyicos-8-en-2-yl]decanamide

N-[(E,2S,3R)-1,3-dihydroxyicos-8-en-2-yl]decanamide

C30H59NO3 (481.4494704)


   

N-dodecanoylsphingosine

N-dodecanoylsphingosine

C30H59NO3 (481.4494704)


A N-acylsphingosine in which the ceramide N-acyl group is specified as dodecanoyl (lauroyl).

   

AcCa(22:1)

AcCa(22:1)

C29H55NO4 (481.413087)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   
   
   

Cer 14:2;O2/15:0;2OH

Cer 14:2;O2/15:0;2OH

C29H55NO4 (481.413087)


   

Cer 14:2;O2/15:0;3OH

Cer 14:2;O2/15:0;3OH

C29H55NO4 (481.413087)


   

Cer 14:2;O2/15:0;O

Cer 14:2;O2/15:0;O

C29H55NO4 (481.413087)


   
   

Cer 15:2;O2/14:0;2OH

Cer 15:2;O2/14:0;2OH

C29H55NO4 (481.413087)


   

Cer 15:2;O2/14:0;3OH

Cer 15:2;O2/14:0;3OH

C29H55NO4 (481.413087)


   

Cer 15:2;O2/14:0;O

Cer 15:2;O2/14:0;O

C29H55NO4 (481.413087)


   
   

Cer 16:2;O2/13:0;2OH

Cer 16:2;O2/13:0;2OH

C29H55NO4 (481.413087)


   

Cer 16:2;O2/13:0;3OH

Cer 16:2;O2/13:0;3OH

C29H55NO4 (481.413087)


   

Cer 16:2;O2/13:0;O

Cer 16:2;O2/13:0;O

C29H55NO4 (481.413087)


   
   

Cer 17:2;O2/12:0;2OH

Cer 17:2;O2/12:0;2OH

C29H55NO4 (481.413087)


   

Cer 17:2;O2/12:0;3OH

Cer 17:2;O2/12:0;3OH

C29H55NO4 (481.413087)


   

Cer 17:2;O2/12:0;O

Cer 17:2;O2/12:0;O

C29H55NO4 (481.413087)


   
   

Cer 18:2;O2/11:0;2OH

Cer 18:2;O2/11:0;2OH

C29H55NO4 (481.413087)


   

Cer 18:2;O2/11:0;3OH

Cer 18:2;O2/11:0;3OH

C29H55NO4 (481.413087)


   

Cer 18:2;O2/11:0;O

Cer 18:2;O2/11:0;O

C29H55NO4 (481.413087)


   
   

Cer 19:2;O2/10:0;2OH

Cer 19:2;O2/10:0;2OH

C29H55NO4 (481.413087)


   

Cer 19:2;O2/10:0;3OH

Cer 19:2;O2/10:0;3OH

C29H55NO4 (481.413087)


   

Cer 19:2;O2/10:0;O

Cer 19:2;O2/10:0;O

C29H55NO4 (481.413087)